TSS
PVLA

Two Sigma Securities’s Palvella Therapeutics PVLA Stock Holding History

Two Sigma Securities’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-728
Closed -$10.7K – 3802
2024
Q1 		$10.7K Buy
728
+535
+277% +$7.45K ﹤0.01% 2757
2023
Q4 		$2.81K Sell
193
-33
-15% -$604 ﹤0.01% 2918
2023
Q3 		$5.39K Buy
226
+99
+78% +$2.13K ﹤0.01% 2780
2023
Q2 		$1.69K Buy
+127
New +$7.7K ﹤0.01% 2701
2023
Q1 		– Sell
-459
Closed -$38.2K – 3405
2022
Q4 		$38.2K Buy
+459
New +$36.9K ﹤0.01% 2200

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Securities's PVLA Position: Q2 2024 in Review

Two Sigma Securities sold out of Palvella Therapeutics (PVLA) in Q2 2024, closing a stake of 728 shares — an estimated $10.7K sold.

Two Sigma Securities first reported a position in PVLA in Q4 2022 and held it in 5 quarters. The position peaked at $38.2K in Q4 2022. 21 funds tracked by Wall St. Rank hold PVLA as of Q2 2024.

  • Two Sigma Securities reported no remaining Palvella Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 728 Palvella Therapeutics shares in Q2 2024, an estimated $10.7K.
  • Two Sigma Securities first reported a position in Palvella Therapeutics in Q4 2022 and held it in 5 quarters.
  • Two Sigma Securities's Palvella Therapeutics position peaked at $38.2K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.